Cure8 news brief
A reliable, accurate intestinal ultrasound could make routine monitoring easier, faster, and less costly than repeated MRI for people with Crohn’s disease. The study shows strong agreement between ultrasound scores and MRI, suggesting ultrasound may be suitable for tracking inflammatory activity in many patients.
Adults with Crohn’s disease who need repeated imaging, gastroenterologists and radiologists, clinic managers planning diagnostics, and researchers interested in non‑invasive monitoring tools.
This report summarises a research comparison between paired intestinal ultrasound and MRI assessments (504 pairs). The key finding is strong agreement between ultrasound scoring systems and MRI measures of inflammation, with concordance also seen against the Crohn’s Disease Activity Index and inflammatory biomarkers.
The authors and article frame intestinal ultrasound as a practical monitoring tool that may reduce dependence on MRI in some settings. Practical point: Intestinal ultrasound techniques and scoring (for example IBUS-SAS) require trained operators and standardised protocols; availability and local expertise vary.
These results support broader use but do not replace clinical judgement or other tests when needed. Next steps: Clinicians and centres interested in adopting intestinal ultrasound should consider local training, quality assurance, and how ultrasound findings will be integrated with clinical assessment and biomarker results.
This article summarises a single comparative study (504 paired assessments) published in Eur Radiol; ultrasound performance depends on operator skill and local protocols. MRI remains important in complex cases and where ultrasound access or expertise is limited.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study suggests using both faecal calprotectin and intestinal ultrasound together can better identify patients who reach deeper, transmural healing — and those patients had lower risk of bowel-damage progression....
This study suggests intestinal ultrasound findings early after diagnosis — especially achieving “transmural remission” within 3 months — may predict better 1-year outcomes (sustained steroid-free remission and less need...
Noninvasive tests at 3 months after ileocecal resection (ultrasound + fecal calprotectin) may identify patients at high risk of endoscopic recurrence by 6 months. That could help avoid or target postoperative endoscopy...
